Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Ujjawal H Gandhi, PhDMBBS, Hanna Von Haefen, Robert Hoffman, MD PhD, Alexandra Ritts, MD, Sharon Phillips, MSPH, Oluchi Ukaegbu, MD, Samuel Rubinstein, MD, Shelton Lacy Harrell, MSN, Stacey A. Goodman, MD MS, Daniel Lenihan, MD, David Slosky, MD, Rebecca Hung, MD PhD, Robert Frank Cornell, MD

Blood (2017) 130 (Supplement 1): 1881.

https://doi.org/10.1182/blood.V130.Suppl_1.1881.1881

Published: 2017

Journal Articles

Persistent Fever Can be Associated with Transient but Severe Hemophagocytic Lymphohistiocytosis (HLH) in Adult Recipients of Ventricular Assist Devices (VAD) for Treatment of Cardiomyopathy (CM)

Beth Ann Martin, MD, Paul A Cheng, MD, Dipanjan Banerjee, MD MS, Richard-Tien Ha, MD

Blood (2016) 128 (22): 4901.

https://doi.org/10.1182/blood.V128.22.4901.4901

Published: 2016

Journal Articles

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Rammurti T Kamble, MD, Gloria Obi, PhD, Audrey Scholoff, MSN, George Carrum, MD, Lawrence Rice, MD, Arvind Bhimrajan, Jerry Estep

Blood (2015) 126 (23): 5364.

https://doi.org/10.1182/blood.V126.23.5364.5364

Published: 2015

Journal Articles

Impact of Four-Factor Prothrombin Complex Concentrate on Urgent Warfarin-Reversal in Patients with Ventricular Assist Devices Going for Heart Transplants

Ding Wen Wu, MD PhD, Uehlinger Joan, MD, Szymanski James, MD, Mohandas Kala, MD, Ronald Walsh, MD, Sadiqa Karim, MD, Evan Himchak, MD, Ritu Gupta, MD, Daniel Goldstein, MD

Blood (2015) 126 (23): 3568.

https://doi.org/10.1182/blood.V126.23.3568.3568

Published: 2015

Journal Articles

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Esha Kaul, MD, Gunjan L Shah, MD MS, Chakra P Chaulagain, MD, FACP, Raymond L. Comenzo, MD

Blood (2013) 122 (21): 4516.

https://doi.org/10.1182/blood.V122.21.4516.4516

Published: 2013

Journal Articles

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Rammurti Kamble, MD, George Carrum, MD, Lawrence Rice, MD, John J. McCarthy, MD, Kelty R. Baker, MD, Carlos A. Ramos, MD, Horacio Adrogue, MD, Jerry Estep, MD

Blood (2011) 118 (21): 4489.

https://doi.org/10.1182/blood.V118.21.4489.4489

Published: 2011

Journal Articles

Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study.

Heather Landau, MD, Hani Hassoun, MD, Adam D Cohen, MD, Alexander Lesokhin, MD, Christina Bello, Elizabeth Hoover, Elyn R Riedel, MD, Jennifer Ciminiello, RN, NP, Emily McCullagh, RN, NP-C, OCN, Stephen D Nimer, MD, Raymond Comenzo, MD

Blood (2009) 114 (22): 533.

https://doi.org/10.1182/blood.V114.22.533.533

Published: 2009

Journal Articles

Successful Use of Argatroban in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin.

Wendy Y. Tcheng, MD, Wing-Yen Wong, MD

Blood (2004) 104 (11): 4085.

https://doi.org/10.1182/blood.V104.11.4085.4085

Published: 2004

NARROW

Novel Cardiac Biopsy Scoring Tool to Predict Clinical Outcomes in Cardiac Light Chain (AL) Amyloidosis

Persistent Fever Can be Associated with Transient but Severe Hemophagocytic Lymphohistiocytosis (HLH) in Adult Recipients of Ventricular Assist Devices (VAD) for Treatment of Cardiomyopathy (CM)

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Impact of Four-Factor Prothrombin Complex Concentrate on Urgent Warfarin-Reversal in Patients with Ventricular Assist Devices Going for Heart Transplants

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study.

Successful Use of Argatroban in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only